Breast cancer: Treatment reduces death risk by 19%
The drug Kisqali, developed by Novartis, has shown a 19% reduction in the risk of death for patients with early-stage breast cancer.
Published 17m1 sourceImportant
Lire en français
≈ 12s
Click the link to read an article on the topic: